-+ 0.00%
-+ 0.00%
-+ 0.00%

*Eli Lilly 3Q Research & Development Expenses Rose 23% to $4.2B, or 17% of Revenue >LLY

Dow Jones·10/29/2026 10:49:00

請登錄查看新聞詳情